Skip to main content
ANAGENICS LIMITED logo

ANAGENICS LIMITED — Investor Relations & Filings

Ticker · AN1 ISIN · AU0000198095 ASX Manufacturing
Open in API
Filings indexed 1,067 across all filing types
Latest filing 2020-03-26 Regulatory Filings
Country AU Australia
Listing ASX AN1

About ANAGENICS LIMITED

https://anagenics.com

Anagenics Limited is a health and wellness company focused on the development and commercialization of science-based anti-aging and longevity solutions. The company specializes in the research and distribution of clinically validated products targeting hair loss and skin health. Its core portfolio includes the évolis brand, which utilizes proprietary FGF5 inhibitor technology to promote hair growth and improve hair health. Through its subsidiaries, such as Advangen and BLC Cosmetics, the company manages a diverse range of premium skincare and wellness brands. Anagenics operates across international markets, providing consumer-facing products and professional-grade treatments backed by scientific research. The company's strategic focus remains on expanding its presence in the global beauty-tech and wellness sectors by leveraging its intellectual property and distribution networks.

Recent filings

Filing Released Lang Actions
Reinstatement to Official Quotation 1 page 74.0KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from ASX regarding the reinstatement to official quotation of Cellmid Limited's securities after suspension. It mentions the lifting of suspension and references a forthcoming announcement about a new material supply agreement. The document is short (669 characters) and serves as a notice rather than a detailed report or financial statement. It does not contain financial data, management discussion, or regulatory filings beyond the announcement itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and compliance notices that do not fit other specific categories.
2020-03-26 English
Suspension from Official Quotation 2 pages 184.2KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Cellmid Limited regarding a voluntary suspension of its securities from official quotation on the ASX. It references Listing Rule 17.2 and states the suspension is pending the release of an announcement about a new material supply agreement. The document is short (2013 characters) and is an announcement about a trading halt/suspension, not a financial report or detailed filing. It does not contain financial data, management discussion, or regulatory certifications. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and compliance-related notices that do not fit other specific categories.
2020-03-23 English
Trading Halt 2 pages 178.9KB
Regulatory Filings Classification · 95% confidence The document is a market announcement regarding a trading halt requested by Cellmid Limited (ASX: CDY). It references ASX Listing Rule 17.1 and states the halt is pending an announcement about ongoing negotiations for a potential material contract. The document is short (1797 characters) and is an announcement of a trading halt, not a financial report or detailed filing. It does not contain financial data, management discussion, or audit information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and compliance documents that do not fit other specific categories.
2020-03-19 English
Appendix 3G 12 pages 257.9KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3G form submitted to the ASX, which is a notification of the issue, conversion, or payment up of equity securities. It details the issuance of unlisted options under an employee incentive scheme, including the number and type of securities, their exercise prices, and expiration dates. The document is a regulatory announcement about securities issuance rather than a financial report or earnings release. It does not contain financial statements or management discussion but is a formal notification of capital changes related to securities issued. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief announcement of a report (RPA) or a general regulatory filing (RNS), but a specific capital change notification.
2020-03-03 English
Appendix 4D, Half Year Accounts and Presentation 45 pages 3.2MB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX announcement reporting the half-year financial results for the period ended 31 December 2019 (1H FY2020). It includes detailed financial data such as revenue, losses, segment performance, and operational highlights. The text references an attached Interim Report and Directors' report, indicating this is a comprehensive financial report for a period shorter than a full fiscal year. The presence of financial statements, management discussion, and review of operations confirms this is an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a full interim report rather than a brief announcement or summary. Therefore, the correct classification is Interim / Quarterly Report (IR). H1 2020
2020-02-25 English
Cellmid's Evolis Patent to be Granted in China 2 pages 66.3KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement regarding the granting of a patent in China for Cellmid's évolis product technology. It discusses the commercial and strategic significance of the patent grant but does not contain financial statements, management discussion of financial results, or detailed financial data. It is a regulatory announcement about intellectual property and business strategy milestones rather than a financial report or management report. The document length is about 5,394 characters, which is relatively short and focused on a specific event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-02-03 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.